ARCEDI BIOTECH ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About ARCEDI BIOTECH ApS
ARCEDI BIOTECH ApS (CVR number: 25577922) is a company from VEJLE. The company recorded a gross profit of -12655 kDKK in 2024. The operating profit was -37.5 mDKK, while net earnings were -42 mDKK. The profitability of the company measured by Return on Assets (ROA) was -15.4 %, which can be considered poor and Return on Equity (ROE) was -30.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -48.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ARCEDI BIOTECH ApS's liquidity measured by quick ratio was 2.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 4 903.00 | 3 864.00 | -8 906.00 | -7 228.00 | -12 655.00 |
EBIT | -4 549.00 | -6 634.00 | -29 568.00 | -31 892.00 | -37 459.00 |
Net earnings | -3 853.00 | -5 779.00 | -24 201.00 | -32 471.00 | -41 961.00 |
Shareholders equity total | -23 346.00 | -29 125.00 | -53 326.00 | -85 797.00 | - 127 758.00 |
Balance sheet total (assets) | 94 583.00 | 114 921.00 | 126 419.00 | 137 153.00 | 135 920.00 |
Net debt | 17 183.00 | 16 007.00 | 163 327.00 | 209 568.00 | 257 738.00 |
Profitability | |||||
EBIT-% | |||||
ROA | -4.2 % | -5.0 % | -18.3 % | -15.8 % | -15.4 % |
ROE | -4.4 % | -5.5 % | -20.1 % | -24.6 % | -30.7 % |
ROI | -15.5 % | -21.7 % | -28.9 % | -16.4 % | -15.8 % |
Economic value added (EVA) | 519.33 | - 246.98 | -16 416.98 | -18 173.38 | -22 742.15 |
Solvency | |||||
Equity ratio | -19.8 % | -20.2 % | -29.7 % | -38.5 % | -48.5 % |
Gearing | -77.6 % | -63.5 % | -309.2 % | -246.2 % | -202.7 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.1 | 0.1 | 1.6 | 1.6 | 2.3 |
Current ratio | 0.1 | 0.1 | 1.6 | 1.7 | 2.6 |
Cash and cash equivalents | 945.00 | 2 486.00 | 1 537.00 | 1 649.00 | 1 270.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | B | BB | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.